Buffett Just Doubled His Stake In This Pharma Stock

Berkshire Hathaway once again upped its stake in Teva last quarter

by Andrea Kramer

Published on May 16, 2018 at 10:23 AM

The shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are up 4.9% to trade at $21.28 -- eyeing their highest close in more than three months -- after the latest regulatory filings revealed that Warren Buffett's Berkshire Hathaway (BRKA) more than doubled its stake in the drug stock last quarter. TEVA shares have already added about 10% this week, and are on pace for their best week since mid-February -- the last time the security enjoyed a big Buffett boost. The stock gapped higher on Monday, after rival Perrigo (PRGO) said it didn't expect Food & Drug Administration (FDA) approval for its generic version of Teva's ProAir inhaler in 2018.

A short squeeze could propel the shares even higher, too. Short interest on Teva Pharmaceutical stock represents six sessions' worth of pent-up buying demand, at the security's average pace of trading.

And if analysts follow Buffett's lead, a round of upgrades could also help TEVA extend its upside breakout. Currently, just three brokerage firms consider the biotech worthy of a "buy" or better rating, compared to 21 doling out tepid "hold" or worse opinions. Plus, the average 12-month price target of $18.82 represents a discount of more than 11% to Teva stock's current perch, leaving the door wide open for price-target hikes to lure more buyers to the table.

Meanwhile, options traders hoping to speculate on TEVA's short-term trajectory can do so at a relative discount. The stock's Schaeffer's Volatility Index (SVI) of 36% is in just the 18th percentile of its annual range, indicating near-term options are pricing in low volatility expectations. In other words, TEVA's short-term options are attractively priced. What's more, the stock's Schaeffer's Volatility Scorecard (SVS) sits at 99 (out of 100), indicating the shares have handily exceeded options traders' volatility expectations in the past year.
Semiconductor Sell-Off Could be Good News for This Chip Stock
Pullbacks to the 320-day moving average have marked buying opportunities
Time To Bet On a Netflix Stock Rally
The shares are trading near a trendline that has historically bullish implications
Molina Healthcare Stock Could Make a Big Move Higher
A "buy" signal is flashing for MOH again
From Schaeffer's Pro Traders
Weekly Options Secrets Revealed

Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Tax Plan is Never Going to Grow the Economy… Unless This Is Fixed First
Are you ready for a potential economic reset?
Amedisys Carves Out New Highs on Oppenheimer's Latest Hike
AMED nabbed another new record high earlier today
Walmart Earnings, Tesla Share Spotlight With Turkey, Trade
The retailer's earnings have the Dow headed toward a weekly win
The Tax Plan is Never Going to Grow the Economy… Unless This Is Fixed First
Are you ready for a potential economic reset?